文献检索
文档翻译
深度研究
Zotero 插件
邀请有礼
套餐&价格
历史记录
Suppr
超能文献
应用&插件
A comparison of the toxicity of prothionamide and ethionamide: a report from the research committee of the British Tuberculosis Association.
出版信息
Tubercle. 1968 Jun;49(2):125-35.
PMID:
5243159
Abstract
摘要
文献AI研究员
20分钟写一篇综述,助力文献阅读效率提升50倍。
立即体验
用中文搜PubMed
大模型驱动的PubMed中文搜索引擎
马上搜索
文档翻译
学术文献翻译模型,支持多种主流文档格式。
立即体验
应用&插件
Zotero 插件
浏览器插件
Mac 客户端
Windows 客户端
微信小程序
定价
高级版会员
购买积分包
购买API积分包
服务
文献检索
文档翻译
深度研究
API 文档
MCP 服务
关于我们
关于 Suppr
公司介绍
联系我们
用户协议
隐私条款
关注我们
Suppr 超能文献
核心技术专利:
CN118964589B
侵权必究
粤ICP备2023148730 号-1
Suppr @ 2026
相似文献
1
A comparison of the toxicity of prothionamide and ethionamide: a report from the research committee of the British Tuberculosis Association.
丙硫异烟胺与乙硫异烟胺毒性比较:英国结核病协会研究委员会报告
Tubercle. 1968 Jun;49(2):125-35.
2
A study of acute intolerance to ethionamide, including a comparison with prothionamide, and of the influence of a vitamin B-complex additive in prophylaxis.
一项关于对乙硫异烟胺急性不耐受的研究,包括与丙硫异烟胺的比较,以及复合维生素B添加剂在预防中的作用。
Tubercle. 1969 Jun;50(2):125-43.
3
[Comparative characteristics of the effectiveness and tolerance of ethionamide and prothionamide in the clinical treatment of pulmonary tuberculosis].
[乙硫异烟胺和丙硫异烟胺在肺结核临床治疗中的有效性及耐受性比较特征]
Probl Tuberk. 1973;51(10):37-40.
4
A comparison of therapeutic efficacy and toxicity of ethionamide and prothionamide in Indian patients.
J Indian Med Assoc. 1977 Jan 16;68(2):25-9.
5
[Treatment of patients with pulmonary tuberculosis, complicated by peptic ulcer, with ethionamide and prothionamide].
[用乙硫异烟胺和丙硫异烟胺治疗合并消化性溃疡的肺结核患者]
Probl Tuberk. 1973;51(7):67-70.
6
[Protionamide tolerance in patients with pulmonary tuberculosis showing poor tolerance to ethionamide].
[对乙硫异烟胺耐受性差的肺结核患者的丙硫异烟胺耐受性]
Vrach Delo. 1971 Nov;11:79-81.
7
[Comparative clinical study of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
Probl Tuberk. 1969;47(1):27-33.
8
Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
异烟肼(INH)、链霉素(SM)和乙硫异烟胺(ETA)对初治空洞型肺结核患者进行一年化疗的结果。
Pol Med J. 1966;5(2):339-44.
9
[Isoprodian in ambulatory therapy of pulmonary tuberculosis].
Prax Klin Pneumol. 1980 Dec;34(12):715-8.
10
Serum transaminase levels in pulmonary tuberculosis. Effect of triple treatment with 4-4 1-di-isoamyloxythiocarbanilide or PAS in combination with streptomycin and isoniazid.
肺结核患者的血清转氨酶水平。4-4 1-二异戊氧基硫代碳酰苯胺或对氨基水杨酸与链霉素及异烟肼三联治疗的效果。
Scand J Respir Dis. 1968;49(1):35-41.
引用本文的文献
1
Host Bioenergetic Parameters Reveal Cytotoxicity of Antituberculosis Drugs Undetected Using Conventional Viability Assays.
宿主生物能量参数揭示了常规活力测定法未检测到的抗结核药物的细胞毒性。
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0093221. doi: 10.1128/AAC.00932-21. Epub 2021 Aug 2.
2
Pharmacokinetics of Ethionamide Delivered in Spray-Dried Microparticles to the Lungs of Guinea Pigs.
喷雾干燥微颗粒形式的乙硫异烟胺在豚鼠肺部的药代动力学
J Pharm Sci. 2017 Jan;106(1):331-337. doi: 10.1016/j.xphs.2016.09.033. Epub 2016 Nov 11.
3
Safety and tolerability profile of second-line anti-tuberculosis medications.
二线抗结核药物的安全性和耐受性概况
Drug Saf. 2015 Mar;38(3):253-69. doi: 10.1007/s40264-015-0267-y.
4
[Comparison of prothionamide and ethionamide tolerance in a double blind trial].
[双盲试验中丙硫异烟胺和乙硫异烟胺耐受性的比较]
Beitr Klin Erforsch Tuberk Lungenkr. 1969;140(1):296-303.
5
[Results of chemotherapy in tuberculosis].
[结核病化疗的结果]
Pneumonologie. 1971;145:305-23. doi: 10.1007/BF02095045.